These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis. Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642 [TBL] [Abstract][Full Text] [Related]
6. Measles antibodies as related to HL-A types in multiple sclerosis. Paty DW; Furesz J; Boucher DW; Rand CG; Stiller CR Neurology; 1976 Jul; 26(7):651-5. PubMed ID: 945513 [TBL] [Abstract][Full Text] [Related]
7. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Stendahl-Brodin L; Link H; Möller E; Norrby E Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443 [TBL] [Abstract][Full Text] [Related]
8. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies. Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: cellular and humoral immune responses to several viruses. Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860 [TBL] [Abstract][Full Text] [Related]
10. [Study of 39 cases of multiple sclerosis (MS) including 2 familial cases. Leukocyte migration inhibition test in the presence of measles antigen with and without levamisole. HL-A typing (SD)]. Hainaut J; Ribot C; Lefebvre P; Goasguen J; Piette JP Ann Med Interne (Paris); 1977 Oct; 128(10):767-72. PubMed ID: 931233 [No Abstract] [Full Text] [Related]
12. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. Bertrams HJ; Kuwert EK J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587 [TBL] [Abstract][Full Text] [Related]
13. HLA types and immunity in multiple sclerosis. Visscher BR; Myers LW; Ellison GW; Malmgren RM; Detels R; Lucia MV; Madden DL; Sever JL; Park MS; Coulson AH Neurology; 1979 Dec; 29(12):1561-5. PubMed ID: 574218 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants. Poskanzer DC; Sever JL; Terasaki PI; Prenney LB; Sheridan JL; Park MS J Epidemiol Community Health; 1980 Dec; 34(4):265-70. PubMed ID: 7241025 [TBL] [Abstract][Full Text] [Related]
15. Antibody response to different antigenic sites on measles virus surface polypeptides in patients with multiple sclerosis. Mäkelä MJ J Neurol Sci; 1989 Apr; 90(2):239-46. PubMed ID: 2470864 [TBL] [Abstract][Full Text] [Related]
16. Measles and canine distemper antibody. Presence in sera from patients with multiple sclerosis and matched control subjects. Madden DL; Wallen WC; Houff SA; Shekarchi IC; Leinikki PO; Castellano GA; Sever JL Arch Neurol; 1981 Jan; 38(1):13-5. PubMed ID: 7458716 [TBL] [Abstract][Full Text] [Related]
18. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7). Trouillas P; Betuel H J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365 [TBL] [Abstract][Full Text] [Related]
19. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants. Kuwert EK Acta Neurol Scand Suppl; 1977; 63():23-42. PubMed ID: 66850 [No Abstract] [Full Text] [Related]
20. [Intrathecal secretion of antiviral antibodies in multiple sclerosis in patients in Seville]. Izquierdo G; Druetta E; Navarro G; Galán A; Borobio MV; Angulo S; Quesada MA; Martínez-Parra C Neurologia; 1990 May; 5(5):151-4. PubMed ID: 2169273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]